WO2007029159A1 - A process for the preparation of lyophilized sodium bicarbonate - Google Patents

A process for the preparation of lyophilized sodium bicarbonate Download PDF

Info

Publication number
WO2007029159A1
WO2007029159A1 PCT/IB2006/053085 IB2006053085W WO2007029159A1 WO 2007029159 A1 WO2007029159 A1 WO 2007029159A1 IB 2006053085 W IB2006053085 W IB 2006053085W WO 2007029159 A1 WO2007029159 A1 WO 2007029159A1
Authority
WO
WIPO (PCT)
Prior art keywords
sodium bicarbonate
crystalline
temperature
preparation
less
Prior art date
Application number
PCT/IB2006/053085
Other languages
French (fr)
Inventor
M. V. Rama KRISHNA
Bhupendra Vashista
Sanjay Gade
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of WO2007029159A1 publication Critical patent/WO2007029159A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01DCOMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D7/00Carbonates of sodium, potassium or alkali metals in general
    • C01D7/35Varying the content of water of crystallisation or the specific gravity
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26DRYING
    • F26BDRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing

Definitions

  • the present invention provides a process for the preparation of crystalline lyophilized sodium bicarbonate.
  • Sodium bicarbonate is used as an inactive ingredient in injectable pharmaceutical preparations such as ertapenem, octreotide acetate, fomivirsen sodium, mannitol, and poractant alfa and in oral tablets such as ESTRATEST® (Esterified Estrogens and Methyltestosterone) and terfenadine.
  • Sterile water for injection containing sodium bicarbonate is used for reconstituting certain drugs such as ceftizoxime, cefazolin, cimetidine hydrochloride, cefoxitin sodium and ceftriaxone sodium.
  • Sodium bicarbonate is also used in the preparation of sodium salts of the drugs such as cilastatin and cefotetan.
  • Sodium bicarbonate is also an ingredient in oral solutions for gastrointestinal lavage such as COLYTE ® . It is also used for pH neutralization of drugs such as metronidazole and ascorbic acid prior to parenteral administration.
  • Sodium bicarbonate of higher purity is commercially produced by injecting gaseous carbon dioxide into a sodium carbonate solution of such composition that results in crystallization of sodium bicarbonate as the solution becomes fully saturated with carbon dioxide. The crystals are separated by centrifuging and filtering, and then dried to remove the traces of moisture.
  • sodium bicarbonate wet cake is traditionally dried by using conventional rotary steam tube dryers. Such methods involve high temperature dehydration and steam pressure up to thirty five atmosphere.
  • the dried material usually has high bulk density and the crystals resulting from this process usually have irregular particle size distribution and dendritic structures, which are physically weak and readily disintegrate into finer fragments on handling. Further, at higher temperatures, sodium bicarbonate tends to be converted into sodium carbonate.
  • U.S. Patent No 3,647,365 describes a method to obtain hollow beads of sodium bicarbonate having bulk density of 25 - 32 pounds per cubic foot, and the process involves drying of the product by warming under carbon dioxide environment. Such methods of drying by warming consume considerable time for complete removal of the moisture.
  • U.S. Patent No. 5,290,322 provides a method to prepare sodium bicarbonate crystals having regular particle size distribution by mobile bed crystallization method. However, the method needs to be carried out at a temperature of about 70 0 C under carbon dioxide environment and results in a mean particle size of about 900 microns.
  • the present inventors have now surprisingly found that crystalline sodium bicarbonate with high purity; optimum bulk density and uniform particle size distribution can be prepared in comparatively a shorter reaction time by lyophilizing a solution of sodium bicarbonate.
  • the method does not require carbon dioxide atmosphere, high pressure or temperature conditions, and yet results in a pure product with moisture content less than about 0.25 % w/w.
  • the present method is suitable for industrial preparation of pharmaceutical grade crystalline sodium bicarbonate.
  • a first aspect of the present invention provides a crystalline lyophilized sodium bicarbonate.
  • the crystalline lyophilized sodium bicarbonate of the present invention has bulk density ranging from about 0.10 to about 0.25 g/ml and tapped density ranging from 0.30 to about 0.40 g/ml.
  • a second aspect of the invention provides crystalline lyophilized sodium bicarbonate having particle size wherein 90% of the particles (do 9 ) have particle diameter 40 microns or less.
  • a third aspect of the present invention provides a process for the preparation of crystalline sodium bicarbonate, wherein the process comprises a) lyophilizing the solution of sodium bicarbonate in lyophilizer having tray thickness of about 15 mm or less, and b) isolating crystalline sodium bicarbonate from the reaction mass thereof.
  • Sodium bicarbonate of any morphology or particle size range prepared by any of the prior art methods can be used as a starting substrate.
  • the sodium bicarbonate is dissolved in water at a temperature of about 5° to about 15°C.
  • the solution is optionally filtered through a micron filter and transferred to lyophilizer trays having the temperature of about 0° to about -10 0 C.
  • the thickness of the solution layer on the lyophilizer trays is less than about 15 millimeter.
  • the solution is cooled to a temperature of -20 0 C or less under vacuum. Then the temperature is raised to about 0 0 C, and then to about 10 0 C.
  • the product can further be dried at a temperature of about 15°C or above.
  • Deionised water (3.5 L) was cooled at a temperature of 5° to 10 0 C.
  • Sodium bicarbonate 250 g was added slowly to the deionised water at a temperature of 5° to 10 0 C and stirred until complete dissolution of the solid.
  • the solution was filtered using 0.45 micron filter and transferred to lyophilizer trays, pre-cooled to 0° to -5°C, to form a layer of 8 to 10 millimeter thickness.
  • the solution was frozen to -40 0 C and held at the same temperature for 180 minutes, followed by the application of vacuum (150 mTorr). The temperature was raised to 0 0 C in 300 minutes and held at the same temperature for 600 minutes.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a process for the preparation of crystalline lyophilized sodium bicarbonate.

Description

A PROCESS FOR THE PREPARATION OF LYOPHILIZED SODIUM
BICARBONATE
Field of the Invention The present invention provides a process for the preparation of crystalline lyophilized sodium bicarbonate.
Background of the Invention
Sodium bicarbonate is used as an inactive ingredient in injectable pharmaceutical preparations such as ertapenem, octreotide acetate, fomivirsen sodium, mannitol, and poractant alfa and in oral tablets such as ESTRATEST® (Esterified Estrogens and Methyltestosterone) and terfenadine. Sterile water for injection containing sodium bicarbonate is used for reconstituting certain drugs such as ceftizoxime, cefazolin, cimetidine hydrochloride, cefoxitin sodium and ceftriaxone sodium. Sodium bicarbonate is also used in the preparation of sodium salts of the drugs such as cilastatin and cefotetan. Sodium bicarbonate is also an ingredient in oral solutions for gastrointestinal lavage such as COLYTE®. It is also used for pH neutralization of drugs such as metronidazole and ascorbic acid prior to parenteral administration.
Sodium bicarbonate of higher purity is commercially produced by injecting gaseous carbon dioxide into a sodium carbonate solution of such composition that results in crystallization of sodium bicarbonate as the solution becomes fully saturated with carbon dioxide. The crystals are separated by centrifuging and filtering, and then dried to remove the traces of moisture.
As detailed in PCT Patent Publication No. WO 94/14705, sodium bicarbonate wet cake is traditionally dried by using conventional rotary steam tube dryers. Such methods involve high temperature dehydration and steam pressure up to thirty five atmosphere. The dried material usually has high bulk density and the crystals resulting from this process usually have irregular particle size distribution and dendritic structures, which are physically weak and readily disintegrate into finer fragments on handling. Further, at higher temperatures, sodium bicarbonate tends to be converted into sodium carbonate.
U.S. Patent No 3,647,365 describes a method to obtain hollow beads of sodium bicarbonate having bulk density of 25 - 32 pounds per cubic foot, and the process involves drying of the product by warming under carbon dioxide environment. Such methods of drying by warming consume considerable time for complete removal of the moisture. U.S. Patent No. 5,290,322 provides a method to prepare sodium bicarbonate crystals having regular particle size distribution by mobile bed crystallization method. However, the method needs to be carried out at a temperature of about 700C under carbon dioxide environment and results in a mean particle size of about 900 microns.
Summary of the Invention
The present inventors have now surprisingly found that crystalline sodium bicarbonate with high purity; optimum bulk density and uniform particle size distribution can be prepared in comparatively a shorter reaction time by lyophilizing a solution of sodium bicarbonate. The method does not require carbon dioxide atmosphere, high pressure or temperature conditions, and yet results in a pure product with moisture content less than about 0.25 % w/w. The present method is suitable for industrial preparation of pharmaceutical grade crystalline sodium bicarbonate.
Detailed Description of the Invention
A first aspect of the present invention provides a crystalline lyophilized sodium bicarbonate. The crystalline lyophilized sodium bicarbonate of the present invention has bulk density ranging from about 0.10 to about 0.25 g/ml and tapped density ranging from 0.30 to about 0.40 g/ml.
A second aspect of the invention provides crystalline lyophilized sodium bicarbonate having particle size wherein 90% of the particles (do 9) have particle diameter 40 microns or less. A third aspect of the present invention provides a process for the preparation of crystalline sodium bicarbonate, wherein the process comprises a) lyophilizing the solution of sodium bicarbonate in lyophilizer having tray thickness of about 15 mm or less, and b) isolating crystalline sodium bicarbonate from the reaction mass thereof.
Sodium bicarbonate of any morphology or particle size range prepared by any of the prior art methods can be used as a starting substrate. The sodium bicarbonate is dissolved in water at a temperature of about 5° to about 15°C. The solution is optionally filtered through a micron filter and transferred to lyophilizer trays having the temperature of about 0° to about -100C. The thickness of the solution layer on the lyophilizer trays is less than about 15 millimeter. The solution is cooled to a temperature of -200C or less under vacuum. Then the temperature is raised to about 00C, and then to about 100C. The product can further be dried at a temperature of about 15°C or above.
While the present invention has been described in terms of its specific embodiments, certain modifications and equivalents will be apparent to those skilled in the art and are included within the scope of the present invention.
Example 1: Preparation of Crystalline Lyophilized Sodium Bicarbonate:
Deionised water (3.5 L) was cooled at a temperature of 5° to 100C. Sodium bicarbonate (250 g) was added slowly to the deionised water at a temperature of 5° to 100C and stirred until complete dissolution of the solid. The solution was filtered using 0.45 micron filter and transferred to lyophilizer trays, pre-cooled to 0° to -5°C, to form a layer of 8 to 10 millimeter thickness. The solution was frozen to -400C and held at the same temperature for 180 minutes, followed by the application of vacuum (150 mTorr). The temperature was raised to 00C in 300 minutes and held at the same temperature for 600 minutes. The temperature was further raised to 100C in 120 minutes and held at the same temperature for 600 minutes. The temperature of the reaction mixture so obtained was raised to 15°C in 60 minutes and held at the same temperature for 360 minutes. The temperature was further raised to 25°C in 120 minutes and held at the same temperature for 300 minutes, followed by the release of vacuum to obtain the title compound. Yield: 225 g
Purity: 99.6 % w/w
Loss on Drying: 0.08%
Bulk Density: 0.24 g/ml
Tapped Bulk Density: 0.34 g/ml
Particle Size (measured by Malvern Mastersizer):
D (0.1) D (0.5) D (0.9)
3μ 15μ 37μ

Claims

WE CLAIM: 1. A crystalline lyophilized sodium bicarbonate. 2. A crystalline lyophilized sodium bicarbonate having a bulk density ranging from about 0.10 to about 0.25 g/ml. 3. A crystalline lyophilized sodium bicarbonate having a tapped density ranging from about 0.30 to about 0.40 g/ml. 4. A crystalline lyophilized sodium bicarbonate having particle size wherein 90% of the particles (do 9) have particle diameter of 40 microns or less. 5. A process for the preparation of crystalline lyophilized sodium bicarbonate, wherein the process comprises, a) lyophilizing the solution of sodium bicarbonate in lyophilizer having tray thickness of about 15 mm or less, and b) isolating crystalline sodium bicarbonate from the reaction mass thereof. 6. A process as claimed in claim 5, wherein the solution of sodium bicarbonate is obtained by dissolving sodium bicarbonate in water. 7. A process as claimed in claim 6, wherein sodium bicarbonate is dissolved at a temperature of about 15°C or less. 8. A process as claimed in claim 5, wherein step a) is carried out at a temperature of about -200C or less. 9. A process as claimed in claim 5, wherein the reaction mixture is filtered before lyophilizing. 10. A process as claimed in claim 5, wherein step a) is carried out under vacuum.
PCT/IB2006/053085 2005-09-05 2006-09-01 A process for the preparation of lyophilized sodium bicarbonate WO2007029159A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2364/DEL/2005 2005-09-05
IN2364DE2005 2005-09-05

Publications (1)

Publication Number Publication Date
WO2007029159A1 true WO2007029159A1 (en) 2007-03-15

Family

ID=37564334

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/053085 WO2007029159A1 (en) 2005-09-05 2006-09-01 A process for the preparation of lyophilized sodium bicarbonate

Country Status (2)

Country Link
CN (1) CN101282908A (en)
WO (1) WO2007029159A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2760998A4 (en) * 2011-11-22 2015-05-13 Siemens Healthcare Diagnostics Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof
RU2670956C2 (en) * 2012-12-03 2018-10-26 Омрикс Биофармасьютикалс Лтд. Thrombin solution and methods for use thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114920269B (en) * 2022-06-28 2022-11-08 浙江天瑞药业有限公司 Preparation method of sodium bicarbonate for injection
CN116282080B (en) * 2023-04-07 2024-05-03 赣州赛可韦尔科技有限公司 Continuous freezing production process of sodium sulfate in waste lithium iron phosphate battery recovery process

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485086A (en) * 1983-04-11 1984-11-27 Wong Dennis W Radiolabeled tumor imaging agent and method of preparation
WO1992002455A1 (en) * 1990-08-06 1992-02-20 Bicarbon Industrial E Comercial Process for obtaining of sodium and potassium bicarbonates by dry route
US5130305A (en) * 1988-11-14 1992-07-14 Erbamont, Inc. Cyclophosphamide - sodium bicarbonate lyophilizates
US5411750A (en) * 1993-04-27 1995-05-02 Church & Dwight Co., Inc. Ultrafine sodium bicarbonate powder

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485086A (en) * 1983-04-11 1984-11-27 Wong Dennis W Radiolabeled tumor imaging agent and method of preparation
US5130305A (en) * 1988-11-14 1992-07-14 Erbamont, Inc. Cyclophosphamide - sodium bicarbonate lyophilizates
WO1992002455A1 (en) * 1990-08-06 1992-02-20 Bicarbon Industrial E Comercial Process for obtaining of sodium and potassium bicarbonates by dry route
US5411750A (en) * 1993-04-27 1995-05-02 Church & Dwight Co., Inc. Ultrafine sodium bicarbonate powder

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2760998A4 (en) * 2011-11-22 2015-05-13 Siemens Healthcare Diagnostics Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof
US9244085B2 (en) 2011-11-22 2016-01-26 Siemens Healthcare Diagnostics Inc. Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof
RU2670956C2 (en) * 2012-12-03 2018-10-26 Омрикс Биофармасьютикалс Лтд. Thrombin solution and methods for use thereof
RU2670956C9 (en) * 2012-12-03 2018-11-21 Омрикс Биофармасьютикалс Лтд. Thrombin solution and methods for use thereof
US10479987B2 (en) 2012-12-03 2019-11-19 Omrix Biopharmaceuticals Ltd. Thrombin solution and methods of use thereof
US11225652B2 (en) 2012-12-03 2022-01-18 Omrix Biopharmaceuticals Ltd. Thrombin solution and methods of use thereof
US11993797B2 (en) 2012-12-03 2024-05-28 Omrix Biopharmaceuticals Ltd. Thrombin solution and methods of use thereof

Also Published As

Publication number Publication date
CN101282908A (en) 2008-10-08

Similar Documents

Publication Publication Date Title
CN100484525C (en) Pantoprazole sodium freeze-dried powder injection and preparing method thereof
JP2004532277A5 (en)
WO2014195966A2 (en) Amorphous form of canagliflozin and process for preparing thereof
WO2007029159A1 (en) A process for the preparation of lyophilized sodium bicarbonate
KR100647951B1 (en) Purification and crystallization process for riboflavin
MX2013001251A (en) Highly crystalline valsartan.
CN101618012B (en) Insoluble medicine solid dispersoid and preparation method thereof
CN105055342A (en) Sodium ilaprazole medicine composition freeze-dried powder injection for treating peptic ulcer
JP4965013B2 (en) Method for producing spray granules containing riboflavin
CA2319514A1 (en) Spray drying of pharmaceutical formulations containing amino acid-based materials
EP2503990B1 (en) Process for the preparation of gadobenate dimeglumine complex in a solid form
CN101912370B (en) D(-)-sulbenicillin disodium powder for injection and preparation process thereof
CN108727448B (en) Spiromycin antibiotic spherical crystal and preparation method thereof
US20060263424A1 (en) Pharmaceutical compositions comprising clavulanic acid
Rams-Baron et al. Amorphous drug preparation methods
CN111454255A (en) Preparation method of small-particle-size azilsartan
JP2004059585A (en) Stable amorphous calcium pseudomonate and preparative method for the same
US20040007689A1 (en) Process for controlling the hydrate mix of a compound
EP1534721B1 (en) Process for controlling the hydrate mix of the disodium salt of fosfluconazole
JP3931884B2 (en) Tablet manufacturing method
CN104306341A (en) Lansoprazole special superfine powder freeze-dried preparation and preparing method thereof
CN104910136B (en) A kind of compound of pantoprazole sodium and preparation thereof adopting particle process crystal product molecule to assemble to prepare with form optimisation technique
CN112573547A (en) Preparation method of nano lithium carbonate
JP2022542866A (en) Process for obtaining amorphous remimazolam besilate
CN116589483A (en) Preparation method of high-purity flomoxef sodium for injection

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680037872.9

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2841/DELNP/2008

Country of ref document: IN

122 Ep: pct application non-entry in european phase

Ref document number: 06795888

Country of ref document: EP

Kind code of ref document: A1